Home
Chronic Obstructive Pulmonary Disorders (COPD)
21 November 2001
Chronic Obstructive Pulmonary Disorders (COPD)
A unique opportunity to learn from leading industry experts including:

Dr Thomas Eichholtz, GlaxoSAE Media GroupthKline
Dr Philip Barr, Chief Operating Officer, Arriva Pharmaceuticals
Dr Anthony Sandrasagra, Vice President, EpiGenesis Pharmaceuticals
Dr Gwynneth Clay, Project Manager, PPL Therapeutics
Dr Mark Parry Billings, Director, Research & Development, Innovata Biomed
Dr John Staniforth, Chief Scientific Officer, Vectura Drug Delivery
Dr Carmen Skurdal, Clinical Director, Cardiopulmonary programmes, Gentiva Health Services
Dr Johannes Christof Stein, International Business Development Manager, PARI Aerosol Research Institute
Laurie DiModica, Senior Analyst, Decision Resources
Dr Susan Lawlor, Senior Analyst Datamonitor Healthcare, Datamonitor

Conference agenda

clock

8:30

Registration and Coffee

clock

9:00

Introduction to the new product development (npd) processes

clock

10:00

Issues arising from the conference

clock

10:45

Morning Coffee

clock

11:15

Workshop sessions – Issue exploration

clock

12:00

Plenary session - Feedback & review

clock

12:45

Lunch

clock

13:30

The global market for COPD

clock

14:00

Building a value proposition for COPD (group work)

clock

15:15

Afternoon Tea

clock

15:45

Plenary session & feedback

clock

16:15

A COPD global market

  • issues unresolved
  • realism in defining the potential
  • initiatives for NPD teams
  • favourable outcomes for patients in 2010
  • clock

    17:00

    Summary and review

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Dr Anthony Sandrasagra

    Dr Anthony Sandrasagra, Vice President, EpiGenesis Pharmaceuticals

    clock

    9:10

    STRATEGIC OVERVIEW OF THE COPD MARKET

    Dr Susan Lawlor

    Dr Susan Lawlor, Senior Analyst, Datamonitor Healthcare, Datamonitor

  • The global COPD market
  • Patient education and compliance
  • Types of medications in use, analysis
  • Meeting the unmet needs of COPD treatment
  • Market forecasts
  • clock

    9:40

    EXISTING AND NEW DRUGS FOR COPD

    Laurie DeModica

    Laurie DeModica, Senior Analyst, Decision Resources

  • COPD Treatment Overview: The Main Goals of Available COPD Therapies
  • Existing Products (b-agonists, Inhaled corticosteroids, Anticholinergics, Methylxanthine Derivatives, Leukotriene Antagonists, Smoking Cessation Products, Others)
  • Combination Therapies
  • Clinical Trials for Respiratory Drugs
  • Current Status of the COPD Drugs Market: Where are the Opportunities for Development?
  • How Close is the Breakthrough?
  • clock

    10:20

    SELECTING AN EFFECTIVE DELIVERY TECHNOLOGY

    Dr Mark Parry Billings

    Dr Mark Parry Billings, Director, Research and Development, Innovata Biomed

  • Overview of delivery options and recent advances
  • Selection of the optimal technology
  • Key challenges in development and registration
  • Future perspectives
  • clock

    11:00

    Morning Coffee

    clock

    11:20

    ADVANCES IN PULMONARY DELIVERY TECHNOLOGY

    Professor John Staniforth

    Professor John Staniforth, Chief Scientific Officer, Vectura Drug Delivery

  • Factors affecting successful delivery systems
  • Approaches to achieving site specific delivery
  • Application of novel formulation technology to a product development programme for COPD
  • clock

    12:00

    LIQUID INHALATION IN PULMONARY DELIVERY TECHNOLOGY

    Dr Johannes Christof Stein

    Dr Johannes Christof Stein, International Business Development Manager, PARI Aerosol Research Institute

  • Key points of therapy with respect to the special needs of COPD patients
  • Understanding patient use and misuse of inhalation devices
  • Approaches to overcome unwanted side effects
  • Factors for successful delivery devices
  • New devices: results
  • clock

    12:40

    Lunch

    clock

    13:40

    NEW TARGETS FOR COPD TREATMENT

    Dr Philip Barr

    Dr Philip Barr, Chief Scientific Officer, Arriva

  • Development of early-onset emphysema
  • Progressive development of emphysematous changes in the peripheral airways
  • MMP inhibitors
  • Treatment of AAT deficiency
  • Bifunctional protease inhibitors

    Studies of airway secretions

  • The role of other enzymes in COPD

    Viable targets for therapy in the long term

  • clock

    14:20

    GENE THERAPY

    Dr Thomas Eichholtz

    Dr Thomas Eichholtz, , GlaxoSmithKline

  • Overview
  • Known endogenous and exogenous risk factors in COPD
  • Role of genetic factors in COPD
  • Methods to discover novel susceptibility genes for COPD
  • clock

    15:00

    HEREDITARY COPD

    Dr Gwynneth Clay

    Dr Gwynneth Clay, Project Manager, PPL Therapeutics

  • Proteases as key components of the host immune response
  • Mechanisms to counteract activity of proteases, protease-protease inhibitor balance
  • Critical role of proteases in emphysema
  • Chronic inflammatory response in smoking-related emphysema
  • AAT levels depending on genetic variants (M,S and Z)
  • Recombinant versions of AAT (Prolastin)
  • clock

    15:40

    Afternoon Tea

    clock

    16:00

    RASON TECHNOLOGY: SIMULTANEOUS IN VIVO TARGET VALIDATION AND ANTISENSE THERAPEUTIC DISCOVERY IN THE RESPIRATORY TRACT

    Dr Anthony Sandrasagra

    Dr Anthony Sandrasagra, Vice President, EpiGenesis Pharmaceuticals

    clock

    16:30

    SUCCESSFUL DELIVERY OF COMPLEX INFUSION THERAPY IN THE HOME

    Carmen Skurdal

    Carmen Skurdal, National Clinical Director, Cardiopulmonary Programs, Gentiva Health Services

  • From Clinical trials to Launch
  • Building clinical support services for physicians and patients
  • Clinical care management at home using the “Team” approach
  • Emerging USA health and payment policies that can impact on marketing and distribution
  • clock

    17:00

    Chairman's Closing Remarks and Close of Conference

    Workshops

    COPD Market Mapping

    COPD Market Mapping

    The Hatton, at etc. venues
    22 November 2001
    London, United Kingdom

    The Hatton, at etc. venues

    51/53 Hatton Garden
    London EC1N 8HN
    United Kingdom

    The Hatton, at etc. venues

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.